Cargando…
Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
It is common for patients to have limited access to oral antineoplastics or to discontinue treatment because of cost. Such oral treatments are also discontinued because of toxicity, disease progression, or death, resulting in unused portions of these medications. Policies for the subsequent use or d...
Autores principales: | Layton, Jodi L., Lewis, Brian, Ryan, Charles, Beer, Tomasz M., Sartor, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519754/ https://www.ncbi.nlm.nih.gov/pubmed/30568023 http://dx.doi.org/10.1634/theoncologist.2018-0565 |
Ejemplares similares
-
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market
por: Shih, Ya-Chen Tina, et al.
Publicado: (2021) -
Therapeutic drug monitoring of oral targeted antineoplastic drugs
por: Mueller-Schoell, Anna, et al.
Publicado: (2020) -
Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach
por: Rattner, Jodi, et al.
Publicado: (2017) -
The Role of Cyclooxygenase Inhibition in the Antineoplastic Effects of Nonsteroidal Antiinflammatory Drugs (Nsaids)
por: Shiff, Steven J., et al.
Publicado: (1999) -
Green supply chain decision of discarded drugs recycling: Evolutionary game and strategy simulation
por: Wang, Chao, et al.
Publicado: (2023)